Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kligabalin monotherapy for occipital neuralgia (8‑day exploratory study)
ChiCTR2600127084Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of kligabalin in Occipital neuralgia (ON), sponsored by The Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Numerical Rating Scale (NRS) Score. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
kligabalin
03
Conditions
Occipital neuralgia (ON)
Beyond the preview
Go deeper on ChiCTR2600127084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127084.